Mitochondrial potential reflects T cell fitness and function during cancer immunotherapy
Paul L Lindau, Alex Nesta, Caroline E. Roe, Madelyn D. Landis et autres
1 citationThe Journal of Immunology
W. Kimryn Rathmell
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
533Publications signalées
100263Citations signalées
1Affiliations récentes
Institutions déclarées
Domaines associés
Renal cell carcinoma treatmentCancer Genomics and DiagnosticsCancer, Hypoxia, and MetabolismRenal and related cancersEpigenetics and DNA Methylation
Publications récentes
Flipping the narrative on launching a rewarding career in academic medicine
W. Kimryn Rathmell, Lalita A. Shevde
0 citationsNature Cancer
Targeted Metabolomic Methods for 13 C Stable Isotope Labeling with Uniformly Labeled Glucose and Glutamine Using Liquid Chromatography–Tandem Mass Spectrometry (LC–MS/MS)
Erin Q. Jennings, W. Kimryn Rathmell, Jeffrey C. Rathmell
2 citationsJournal of Proteome Research
Assessing pathological response to neoadjuvant therapy in renal cell carcinoma: a systematic review and guidelines for sampling and reporting standards from the International Neoadjuvant Kidney Cancer Consortium
James P. Blackmur, J C Koen van der Mijn, Anne Y. Warren, Lisa Browning et autres
9 citationsThe Lancet Oncology
A SETD2–CDK1–lamin axis maintains nuclear morphology and genome stability
Abid Khan, Cheng Zhang, Phu Hung Nguyen, Lucas Collins et autres
14 citationsNature Cell Biology
SETD2 loss sensitizes cells to PI3Kβ and AKT inhibition
Aaron R. Lim, Kathryn H. Gessner, Esteban Terzo, Cheryl L. Walker et autres
0 citationsCarolina Digital Repository (University of North Carolina at Chapel Hill)
Correction: SETD2 loss sensitizes cells to PI3Kβ and AKT inhibition
Leah M. Farmer, Valerie M. Jansen, Anna Chytil, Kathryn H. Gessner et autres
0 citationsCarolina Digital Repository (University of North Carolina at Chapel Hill)
Vaccines in cancer treatment and prevention: the time is now
William E. Becker, W. Kimryn Rathmell
4 citationsJournal of Clinical Investigation
Potentiating cancer immunotherapies with modular albumin-hitchhiking nanobody–STING agonist conjugates
Blaise R. Kimmel, Karan Arora, Neil C. Chada, Vijaya Bharti et autres
57 citationsNature Biomedical Engineering
Abstract 5396: NDUFA4L2 inhibits oxidative phosphorylation to drive primary tumor escape
Emily N. Arner, Erin Q. Jennings, Daniel R. Crooks, C. Ricketts et autres
0 citationsCancer Research
Supplementary Protocol S1 from A Phase II Trial of the WEE1 Inhibitor Adavosertib in SETD2-Altered Advanced Solid Tumor Malignancies (NCI 10170)
Edward Maldonado, W. Kimryn Rathmell, Geoffrey I. Shapiro, Naoko Takebe et autres
0 citations
Supplementary Table S4 from A Phase II Trial of the WEE1 Inhibitor Adavosertib in SETD2-Altered Advanced Solid Tumor Malignancies (NCI 10170)
Edward Maldonado, W. Kimryn Rathmell, Geoffrey I. Shapiro, Naoko Takebe et autres
0 citations
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.